CLINICAL_TRIALS
trial_result
· 2019-12-23
Clinical Trial Update: Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment [Phase 2]
Summary
Phase 2 dose-ranging study of oral COL-144 in acute migraine treatment completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine Disorders | Phase 2 | Status: COMPLETED | Results posted: 2019-12-23